• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体治疗的现状。

The state of antibody therapy.

机构信息

Department of Medical Laboratory Technology, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

出版信息

Hum Immunol. 2010 Dec;71(12):1243-50. doi: 10.1016/j.humimm.2010.09.007. Epub 2010 Sep 16.

DOI:10.1016/j.humimm.2010.09.007
PMID:20849901
Abstract

Therapeutic antibodies are widely used in the treatment of various diseases and disease conditions, including cardiovascular diseases, autoimmune disorders, malignancies, and infections. With at least 23 therapeutic agents currently in clinical use and a successful business generating large revenues, major technological advances are now in place to improve the specificity and efficacy of those antibodies already in the market and also generate new, safe and effective macromolecules for the treatment of other ailments. This review provides a summary of the current state of antibody therapy, highlights and discusses recent developments in the field of antibody-based therapeutics production, combination therapy and shows the status of some of the agents that are in clinical trial.

摘要

治疗性抗体被广泛应用于各种疾病和病症的治疗,包括心血管疾病、自身免疫性疾病、恶性肿瘤和感染。目前至少有 23 种治疗药物在临床使用,一个成功的业务产生了巨大的收入,重大技术进步已经到位,以提高那些已经在市场上的抗体的特异性和疗效,并产生新的、安全和有效的治疗其他疾病的大分子药物。本综述概述了抗体治疗的现状,强调并讨论了抗体治疗生产、联合治疗领域的最新进展,并展示了一些处于临床试验阶段的药物的现状。

相似文献

1
The state of antibody therapy.抗体治疗的现状。
Hum Immunol. 2010 Dec;71(12):1243-50. doi: 10.1016/j.humimm.2010.09.007. Epub 2010 Sep 16.
2
Antibody-based therapeutics in oncology.肿瘤学中基于抗体的治疗方法。
Expert Rev Anticancer Ther. 2003 Feb;3(1):107-21. doi: 10.1586/14737140.3.1.107.
3
Tailor-made antibody therapeutics.定制抗体疗法。
Methods. 2005 May;36(1):11-24. doi: 10.1016/j.ymeth.2005.01.002.
4
Selection, design, and engineering of therapeutic antibodies.治疗性抗体的筛选、设计与工程
J Allergy Clin Immunol. 2005 Oct;116(4):731-6; quiz 737. doi: 10.1016/j.jaci.2005.08.003.
5
Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy.单克隆抗体作为肿瘤学治疗药物及抗体基因治疗
Cell Res. 2007 Feb;17(2):89-99. doi: 10.1038/sj.cr.7310143.
6
Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.使用偶联和非偶联单克隆抗体进行人类癌症检测与免疫治疗。
Anticancer Res. 1996 Mar-Apr;16(2):661-74.
7
Development of humanized antibodies as cancer therapeutics.作为癌症治疗药物的人源化抗体的研发。
Methods. 2005 May;36(1):84-95. doi: 10.1016/j.ymeth.2005.01.008.
8
Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.英夫利昔单抗在自身免疫性和非自身免疫性疾病中的潜在非标签使用:一项综述。
Autoimmun Rev. 2005 Mar;4(3):144-52. doi: 10.1016/j.autrev.2004.08.004.
9
Human antibodies from transgenic animals.来自转基因动物的人类抗体。
Nat Biotechnol. 2005 Sep;23(9):1117-25. doi: 10.1038/nbt1135.
10
[Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].[治疗性单克隆抗体:一段简短的历史、大量的工程技术以及……一些临床成功案例]
Transfus Clin Biol. 2005 Jun;12(2):114-22. doi: 10.1016/j.tracli.2005.04.016.

引用本文的文献

1
Mice carrying the full-length human immunoglobulin loci produce antigen-specific human antibodies with the lambda light chain.携带全长人类免疫球蛋白基因座的小鼠会产生具有λ轻链的抗原特异性人类抗体。
iScience. 2024 Oct 28;27(12):111258. doi: 10.1016/j.isci.2024.111258. eCollection 2024 Dec 20.
2
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy.精密设计的PROTACs可将癌症治疗中的非组织效应降至最低。
Front Mol Biosci. 2024 Nov 22;11:1505255. doi: 10.3389/fmolb.2024.1505255. eCollection 2024.
3
Single-domain antibodies as therapeutics for solid tumor treatment.
单域抗体作为实体瘤治疗的药物。
Acta Pharm Sin B. 2024 Jul;14(7):2854-2868. doi: 10.1016/j.apsb.2024.03.016. Epub 2024 Mar 15.
4
Development and biophysical characterization of a humanized FSH-blocking monoclonal antibody therapeutic formulated at an ultra-high concentration.开发并对超高浓度配制的人源化 FSH 阻断型单克隆抗体治疗药物进行生物物理特性鉴定。
Elife. 2023 Jun 19;12:e88898. doi: 10.7554/eLife.88898.
5
Development and Biophysical Characterization of a Humanized FSH-Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra-High Concentration.一种超高浓度配制的人源化促卵泡激素阻断单克隆抗体疗法的研发及生物物理特性分析
bioRxiv. 2023 May 11:2023.05.11.540323. doi: 10.1101/2023.05.11.540323.
6
Evaluation of antibody responses against the whole virions of goatpox and sheeppox viruses after subcutaneous immunization of rabbits.兔皮下免疫后针对山羊痘病毒和绵羊痘病毒全病毒粒子的抗体反应评估
Heliyon. 2022 Nov 17;8(11):e11745. doi: 10.1016/j.heliyon.2022.e11745. eCollection 2022 Nov.
7
Can Immunization of Hens Provide Oral-Based Therapeutics against COVID-19?给母鸡接种疫苗能否提供针对新冠病毒病的口服疗法?
Vaccines (Basel). 2020 Aug 28;8(3):486. doi: 10.3390/vaccines8030486.
8
Targeting MCF-7 Cell Line by Listeriolysin O Pore Forming Toxin Fusion with AHNP Targeted Peptide.通过将李斯特菌溶血素O孔形成毒素与AHNP靶向肽融合来靶向MCF-7细胞系。
Adv Biomed Res. 2019 May 27;8:33. doi: 10.4103/abr.abr_18_19. eCollection 2019.
9
Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer.人胚胎干细胞上的癌胚胎抗原的保守性使针对癌症的单克隆抗体的发现成为可能。
Sci Rep. 2018 Aug 2;8(1):11608. doi: 10.1038/s41598-018-30070-z.
10
Theory for the Liquid-Liquid Phase Separation in Aqueous Antibody Solutions.水溶液中抗体溶液液-液相分离的理论。
J Phys Chem B. 2018 May 31;122(21):5400-5408. doi: 10.1021/acs.jpcb.7b11458. Epub 2018 Jan 27.